Clinical Trials Browser

Phase 2 × Epstein-Barr Virus Infections × Bortezomib × Clear all

NCT01058239 2018-02-15

Bortezomib Plus Rituximab for EBV+ PTLD

Phase 2 Completed

7 enrolled 15 charts

Epstein-Barr Virus Infections